Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

p53 inhibits entry into mitosis when DNA synthesis is blocked

Abstract

Human and mouse fibroblasts with normal p53 fail to enter mitosis when DNA synthesis is blocked by aphidicolin or hydroxyurea. Isogenic p53-null fibroblasts do enter mitosis with incompletely replicated DNA, revealing that p53 contributes to a checkpoint that ensures that mitosis does not occur until DNA synthesis is complete. When treated with N-(phosphonacetyl)-L-aspartate (PALA), which inhibits pyrimidine nucleotide synthesis, leading to synthesis of damaged DNA from highly unbalanced dNTP pools, p53-null cells enter mitosis after they have completed DNA replication, but cells with wild-type p53 do not, revealing that p53 also mediates a checkpoint that monitors the quality of newly replicated DNA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 5
Figure 4
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Agarwal ML, Agarwal A, Taylor WR, Chernova O, Sharma Y and Stark GR. . 1998a Proc. Natl. Acad. Sci. USA (in press).

  • Agarwal ML, Agarwal A, Taylor WR and Stark GR. . 1995 Proc. Natl. Acad. Sci. USA 92: 8493–8497.

  • Agarwal ML, Agarwal A, Taylor WR, Wang Z, Wagner EF and Stark GR. . 1997 Oncogene 15: 1035–1043.

  • Agarwal ML, Taylor WR, Chernov MV, Chernova OB and Stark GR. . 1998b J. Biol. Chem. 273: 1–4.

  • Allen JB, Zhou Z, Siede W, Friedberg EC and Elledge SJ. . 1994 Genes Dev. 8: 2401–2415.

  • Anderson GR, Volpe CM, Russo CA, Stoler DL and Miloro SM. . 1995 J. Surg. Res. 59: 666–674.

  • Attardi LD, Lowe SW, Brugarolas J and Jacks T. . 1996 EMBO J. 15: 3696–3701.

  • Bernat RL, Borisy GG, Rothfield NF and Earnshaw WC. . 1990 J. Cell. Biol. 111: 1519–1533.

  • Blasina A, Paegle ES and McGowan CH. . 1997 Mol. Cell. Biol. 8: 1013–1023.

  • Cayrol C, Knibiehler M and Ducommun B. . 1998 Oncogene 16: 311–320.

  • Chadee DN, Taylor WR, Hurta RAR, Allis CD, Wright JA and Davie JR. . 1995 J. Biol. Chem. 270: 20098–20105.

  • Chang TH, Ray FA, Thompson DA and Schlegel R. . 1997 Oncogene 14: 2383–2393.

  • Chen G, Zhu J, Shi X, Ni J, Zhong H, Si G, Jin X, Tang W, Li X, Xong S, Shen Z, Sun G, Ma J, Zhang P, Zhang T, Gazin C, Naoe T, Chen S, Wang Z and Chen Z. . 1996 Blood 88: 1052–1061.

  • Chernova OB, Chernov MV, Agarwal ML, Taylor WR and Stark GR. . 1995 Trends Biochem., Sci. 20: 431–434.

  • Chernova OB, Chernov MV, Ishizaka Y, Agarwal ML and Stark GR. . 1998 Mol. Cell. Biol. 18: 536–545.

  • Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH and Reid B. . 1995 Science 267: 1353–1356.

  • Di Leonardo A, Khan SH, Linke SP, Greco V, Seidita G and Wahl GM. . 1997 Cancer Res. 57: 1013–1019.

  • Di Leonardo A, Linke SP, Clarkin K and Wahl GM. . 1994 Genes Dev. 8: 2540–2551.

  • Di Leonardo A, Linke SP, Yin Y and Wahl GM. . 1993 Cold Spring Harb. Symp. Quant. Biol. 58: 655–667.

  • Donehower LA, Harvey M, Slagle BL, McArthur M, Montgomery LA, Butel JS and Bradley A. . 1992 Nature 356: 215–221.

  • Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ and Reed SI. . 1994 Cell 76: 1013–1023.

  • Dulic V, Stein GH, Far DF and Reed SI. . 1998 Mol. Cell. Biol. 18: 546–557.

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–882.

  • Elledge S. . 1996 Science 274: 1664–1672.

  • Enoch T and Nurse P. . 1990 Cell 60: 665–673.

  • Fritsche M, Haessler C and Brandner G. . 1993 Oncogene 8: 307–318.

  • Fukasawa K, Choi T, Kuriyama R, Rulong S and Vande Woude GF. . 1996 Science 271: 1744–1747.

  • Funk WD, Pak DT, Karas RH, Wright WE and Shay JW. . 1992 Mol. Cell. Biol. 12: 2866–2871.

  • Furnari B, Rhind N and Russell P. . 1997 Science 277: 1495–1497.

  • Gossen M and Bujard H. . 1992 Proc. Natl. Acad. Sci. USA 89: 5547–5551.

  • Graeber AJ, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ. . 1996 Nature 379: 88–91.

  • Greenblatt MS, Bennett WP, Hollstein M and Harris CC. . 1994 Cancer Res. 54: 4855–4878.

  • Guadagno TM and Newport JW. . 1996 Cell 84: 73–82.

  • Hain J, Crompton NE, Burkart W and Jaussi R. . 1993 Cancer Res. 53: 1507–1510.

  • Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP and Wei N. . 1995 Mol. Biol. Cell 6: 387–400.

  • Hartwell L and Weinert T. . 1989 Science 246: 629–634.

  • Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A and Donehower LA. . 1993 Oncogene 8: 2457–2467.

  • Heald R, McLoughlin M and McKeon F. . 1993 Cell 74: 463–474.

  • Hermeking H, Lengauer C, Polyak K, He T, Zhang L, Thiagalingam S, Kinzler KW and Vogelstein B. . 1997 Mol. Cell 1: 3–11.

  • Herzinger T, Fund JO, Hillmer K, Eick D, Wolf DA and Kind P. . 1995 Oncogene 11: 2151–2156.

  • Hughes TA and Cook PR. . 1996 Exp. Cell. Res. 222: 275–280.

  • Hupp TR, Sparks A and Lane DP. . 1995 Cell 83: 237–245.

  • Jacobberger JW. . 1991 Methods 2: 207–218.

  • Jin P, Gu Y and Morgan DO. . 1996 J. Cell. Biol. 134: 963–970.

  • Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. . 1991 Cancer Res. 51: 6304–6311.

  • Kato R and Ogawa H. . 1994 Nucleic Acids Res. 22: 3104–3112.

  • Khanna KK and Lavin MF. . 1995 Oncogene 8: 3307–3312.

  • Ko LJ and Prives C. . 1996 Genes Dev. 10: 1054–1072.

  • Krek W and Nigg E. . 1991 EMBO J. 10: 3331–3341.

  • Lane DP. . 1992 Nature 358: 15–16.

  • Levine AJ. . 1997 Cell 88: 323–331.

  • Li FP and Fraumeni JF. . 1969 Ann. Intern. Med. 71: 747–752.

  • Linke SP, Clarkin KC, Di Leonardo A, Tsou A and Wahl GM. . 1996 Genes Dev. 10: 934–947.

  • Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD. . 1992 Cell 70: 923–935.

  • Lu MJ, Dadd CA, Mizzen CA, Perry CA, McLachlan DR, Annunziato AT and Allis CD. . 1994 Chromosma 103: 111–121.

  • Lundgren K, Walworth N, Booher R, Dembski M, Kirschner M and Beach D. . 1991 Cell 64: 1111–1122.

  • Martineau SN, Andreassen PR and Margolis RL. . 1995 J. Cell. Biol. 131: 191–205.

  • Medema RH, Klompmaker R, Smits VAJ and Rijksen G. . 1998 Oncogene 16: 431–441.

  • Minn AJ, Boise LH and Thompson CB. . 1996 Genes Dev. 10: 2621–2631.

  • Miyashita T and Reed JC. . 1995 Cell 80: 293–299.

  • Navas TA, Zhou Z and Elledge SJ. . 1995 Cell 80: 29–39.

  • Niculescu AB III, Chen X, Smeets M, Hengst L, Prives C, Reed SI. . 1998 Mol. Cell. Biol. 18: 629–643.

  • Nishitani H, Ohtsubo M, Yamashita K, Iida H, Pines J, Yasudo H, Shibata Y, Hunter T and Nishimoto T. . 1991 EMBO J. 10: 1555–1564.

  • Nurse P. . 1994 Cell 79: 547–550.

  • Paulson TG, Almasan A, Brody LL and Wahl GM. . 1998 Mol. Cell. Biol. 18: 3089–3100.

  • Peng C, Graves PR, Thoma RS, Wu Z, Shaw AS and Piwnica-Worms H. . 1997 Science 277: 1501–1504.

  • Poon RYC, Jiang W, Toyoshima H and Hunter T. . 1996 J. Biol. Chem. 271: 13282–13291.

  • Saka Y and Yanagida M. . 1993 Cell 74: 383–393.

  • Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H and Elledge SJ. . 1997 Science 277: 1497–1501.

  • Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Malcolm A, Taylor R, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS and Shiloh Y. . 1995 Science 268: 1749–1753.

  • Schlegel R and Pardee AB. . 1986 Science 232: 1264–1266.

  • Shimizu N, Itoh N, Utiyama H and Wahl GM. . 1998 J. Cell. Biol. 140: 1307–1320.

  • Smythe C and Newport JW. . 1992 Cell 68: 787–797.

  • Sorger PK and Murray AW. . 1992 Nature 355: 365–368.

  • Srivastava S, Zou ZQ, Pirollo K, Blattner W and Chang EH. . 1990 Nature 348: 747–749.

  • Steinmann KE, Belinsky GS, Lee D and Schlegel R. . 1991 Proc. Natl. Acad. Sci. USA 88: 6843–6847.

  • Stern DF, Zheng P, Beidler DR and Zerillo C. . 1991 Mol. Cell. Biol. 11: 987–1001.

  • Stewart N, Hicks GG, Paraskevas F and Mowat M. . 1995 Oncogene 10: 109–115.

  • Thompson DA, Belinsky G, Chang TH-T, Jones DL, Schlegel R and Münger K. . 1997 Oncogene 15: 3025–3035.

  • Weinert TG, Kiser L and Hartwell L. . 1994 Genes Dev. 8: 652–665.

  • White AE, Livanos EM and Tlsty TD. . 1996 Genes Dev. 8: 666–677.

  • Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM. . 1992 Cell 70: 937–948.

Download references

Acknowledgements

We gratefully acknowledge gifts of p53-null MEFs from L Donehower (Baylor College of Medicine), MDAH041 cells from M Tainsky (MD Anderson Cancer Center), and antiserum against pH1b from CD Allis (Syracuse University). We also thank Pamela Duncan for technical assistance and Teresa Bendele for assistance with the FACScan analyses. WRT is a Terry Fox Research Fellow supported by funds provided by the Terry Fox Run. This work was supported by grant GM-49345 from the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, W., Agarwal, M., Agarwal, A. et al. p53 inhibits entry into mitosis when DNA synthesis is blocked. Oncogene 18, 283–295 (1999). https://doi.org/10.1038/sj.onc.1202516

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202516

Keywords

This article is cited by

Search

Quick links